The ligand-binding domain of siglec-G is crucial for its selective inhibitory function on B1 cells

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 5406-5414

  Hutzler, Stefan ^a   Özgör, Lamia ^a   Naito Matsui, Yuko ^b   Kläsener, Kathrin ^c,d   Winkler, Thomas H ^a,e   Reth, Michael ^c,d   Nitschke, Lars ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF FREIBURG   (Germany)

^d MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM ION; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; SIALIC ACID; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN G; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; B1 LYMPHOCYTE; B2 LYMPHOCYTE; CALCIUM SIGNALING; CELL EXPANSION; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; FEMALE; GENE MUTATION; IN VITRO STUDY; LIGAND BINDING; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL;

ANIMALS; B-LYMPHOCYTE SUBSETS; CALCIUM SIGNALING; IMMUNOGLOBULIN M; LECTINS; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; ORGAN SPECIFICITY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, B-CELL;

EID: 84901255884     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302875     Document Type: Article

References (22)

1. Crocker, P. R., J. C. Paulson, and A. Varki. 2007. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7: 255-266.
2. Jellusova, J., and L. Nitschke. 2011. Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front Immunol 2: 96.
3. Hoffmann, A., S. Kerr, J. Jellusova, J. Zhang, F. Weisel, U. Wellmann, T. H. Winkler, B. Kneitz, P. R. Crocker, and L. Nitschke. 2007. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat. Immunol. 8: 695-704.
4. Jellusova, J., S. Duber, E. Guckel, C. J. Binder, S. Weiss, R. Voll, and L. Nitschke. 2010. Siglec-G regulates B1 cell survival and selection. J. Immunol. 185: 3277-3284.
5. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
6. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
7. Su, A. I., T. Wiltshire, S. Batalov, H. Lapp, K. A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, G. Kreiman, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101: 6062-6067.
8. Ding, C., Y. Liu, Y. Wang, B. K. Park, C. Y. Wang, P. Zheng, and Y. Liu. 2007. Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation. PLoS ONE 2: e997.
9. Chen, G. Y., X. Chen, S. King, K. A. Cavassani, J. Cheng, X. Zheng, H. Cao, H. Yu, J. Qu, D. Fang, et al. 2011. Amelioration of sepsis by inhibiting sialidasemediated disruption of the CD24-SiglecG interaction. Nat. Biotechnol. 29: 428-435.
10. Chen, G. Y., J. Tang, P. Zheng, and Y. Liu. 2009. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323: 1722-1725.
11. Duong, B. H., H. Tian, T. Ota, G. Completo, S. Han, J. L. Vela, M. Ota, M. Kubitz, N. Bovin, J. C. Paulson, and D. Nemazee. 2010. Decoration of Tindependent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J. Exp. Med. 207: 173-187.
12. Collins, B. E., B. A. Smith, P. Bengtson, and J. C. Paulson. 2006. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling. Nat. Immunol. 7: 199-206.
13. Ghosh, S., C. Bandulet, and L. Nitschke. 2006. Regulation of B cell development and B cell signalling by CD22 and its ligands alpha2,6-linked sialic acids. Int. Immunol. 18: 603-611.
14. Muller, J., I. Obermeier, M. Wöhner, C. Brandl, S. Mrotzek, S. Angermuller, P. C. Maity, M. Reth, and L. Nitschke. 2013. CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling. Proc. Natl. Acad. Sci. U S A 110: 12402-12407.
15. Noben-Trauth, N., G. Köhler, K. Burki, and B. Ledermann. 1996. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res. 5: 487-491.
16. Goodarzi, M. T., and G. A. Turner. 1997. A lectin method for investigating the glycosylation of nanogram amounts of purified glycoprotein. Glycoconj. J. 14: 493-496.
17. Söderberg, O., K. J. Leuchowius, M. Gullberg, M. Jarvius, I. Weibrecht, L. G. Larsson, and U. Landegren. 2008. Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 45: 227-232.
18. Schebesta, A., S. McManus, G. Salvagiotto, A. Delogu, G. A. Busslinger, and M. Busslinger. 2007. Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function. Immunity 27: 49-63.
19. Chen, W., C. Han, B. Xie, X. Hu, Q. Yu, L. Shi, Q. Wang, D. Li, J. Wang, P. Zheng, et al. 2013. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 152: 467-478.
20. Pfrengle, F., M. S. Macauley, N. Kawasaki, and J. C. Paulson. 2013. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22. J. Immunol. 191: 1724-1731.
21. Han, S., B. E. Collins, P. Bengtson, and J. C. Paulson. 2005. Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat. Chem. Biol. 1: 93-97.
22. Jellusova, J., U. Wellmann, K. Amann, T. H. Winkler, and L. Nitschke. 2010. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J. Immunol. 184: 3618-3627.